Trial Profile
A Randomized Study Comparing Sitagliptin In Combination With Metformin Versus Metformin Alone To Prevent Weight Regain In Obese Women With Polycystic Ovary Syndrome (PCOS) Previously Treated With Liraglutide
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Obesity; Weight gain
- Focus Therapeutic Use
- 20 Apr 2017 New trial record
- 04 Apr 2017 Primary endpoint has been met for anthropometric measures of obesity i.e weight change, percentage of weight change and BMI change, according to results presented at The 99th Annual Meeting of the Endocrine Society.
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society.